Splenic B cell populations following CY or PBS treatment.
- Daisuke Kawabata (198993)
- Jeganathan Venkatesh (368025)
- Meera Ramanujam (6826)
- Anne Davidson (6827)
- Christine M. Grimaldi (368026)
- Betty Diamond (367018)
Publication date
February 2013
DOIAbstract
<p>The markers B220 and AA4.1 were used to differentiate mature (B220<sup>+</sup>/AA4.1<sup>−</sup>) and transitional (B220<sup>+</sup>/AA4.1<sup>+</sup>) B cell subsets. The mature B cell gate was used to identify marginal zone (CD21<sup>hi</sup>/CD23<sup>−</sup>) and follicular (CD21<sup>hi/</sup>CD23<sup>pos</sup>) populations and the transitional gate was used to identify T1 (CD21<sup>neg</sup>/HSA<sup>hi</sup>) and T2 (CD21<sup>pos</sup>/HSA<sup>hi</sup>) subsets. Five mice were analyzed at each time point. Representative data are shown. The absolute numbers are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0008418#pone-0008418-t002" target="_blank">Table 2</a>.</p
Add to ORKG